Molly Schroeder

Medicine & Life Sciences

1. Undiagnosed Diseases 100%
2. Phenotype 82%
3. Exome 66%
4. Whole Exome Sequencing 58%
5. Whole Genome Sequencing 57%
6. Genes 51%
7. Intellectual Disability 51%
8. Mosaicism 45%
9. Genome 41%
10. Carrier Proteins 37%
11. Human Genetics 36%
12. Rare Diseases 35%
13. Genetic Models 35%
14. Genetic Databases 33%
15. Interferon Regulatory Factor-2 32%
16. High-Throughput Nucleotide Sequencing 32%
17. Pyruvate Dehydrogenase Complex Deficiency Disease 31%
18. Genomics 29%
19. Neurodevelopmental Disorders 28%
20. Megalencephaly 26%
21. Immunoglobulin G4-Related Disease 25%
22. Neoplasms 25%
23. Therapeutic Human Experimentation 25%
24. Pharmacogenomic Testing 24%
25. Mutation 23%
26. RNA Splice Sites 23%
27. Mitochondrial Diseases 23%
28. Diptera 22%
29. Organ Size 22%
30. Fibroblast Growth Factors 22%
31. Intercellular Junctions 22%
32. Cytogenetic Analysis 21%
33. Muscle Hypotonia 21%
34. Molecular Pathology 21%
35. Developmental Disabilities 20%
36. Translational Medical Research 20%
37. Cytogenetics 20%
38. Growth 19%
39. Human Genome 19%
40. Adenosine Triphosphate 19%
41. Cytoskeleton 18%
42. 3-Methylglutaconic Aciduria 17%
43. Head 16%
44. Eyebrows 16%
45. Inherited Peripheral Neuropathy 16%
46. Eye 15%
47. Alleles 15%
48. Molecular Biology 15%
49. Fibroblasts 14%
50. oligomycin sensitivity-conferring protein 14%